FDA Clearance Tracker · P160017-S122
MiniMed 770G System
Last checked: Nov 20, 2026Latest source record: Aug 20, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Aug 20, 2025
Approved
Time to decision
180 days
Received Feb 21, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P160017-S122
- Device name
- MiniMed 770G System
- Applicant
- Medtronic Minimed, Inc.
- Applicant location
- Northridge, CA
- Received
- Feb 21, 2025
- Decided
- Aug 20, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P160017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for modified labeling for the MiniMed 770G System to include descriptive results of the post-approval study previously mandated under the approval order of P160017.
Source documents
Other decisions for Medtronic Minimed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.